The bacteriocins :: current knowledge and future prospects /
In this volume, a range of experts explore our current understanding of the biology of these important compounds, and identify the prospects for their use in medical and veterinary applications. In so doing, this volume introduces the vast diversity of bacteriocin molecules and mechanisms and brings...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Norfolk, UK :
Caister Academic Press,
2016.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | In this volume, a range of experts explore our current understanding of the biology of these important compounds, and identify the prospects for their use in medical and veterinary applications. In so doing, this volume introduces the vast diversity of bacteriocin molecules and mechanisms and brings readers to the cutting edge of a new 21st century approach to antibiotic discovery and design. Topics covered include: the natural history of bacteriocins; killing strategies and applications of microcins; the mode of action of nuclease colicins; the role of the van der Waals zone in the design of a new family of bacteriocins; the use of pyocins in the treatment of infections; the role of streptococccal bacteriocins as oral probiotics; veterinary applications of bacteriocins (nisin) in treating mastitis, and an exploration of the genetics of bacteriocin resistance. This volume is essential reading for everyone involved in antimicrobial research in academia, biotechnology companies, and the pharmaceutical industry and a recommended volume for all microbiology libraries. |
Beschreibung: | Includes index. |
Beschreibung: | 1 online resource. |
Bibliographie: | Includes bibliographical references and index. |
ISBN: | 9781910190388 1910190381 |
Internformat
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn949884670 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cnu|||unuuu | ||
008 | 160517s2016 enk o 001 0 eng d | ||
040 | |a N$T |b eng |e rda |e pn |c N$T |d YDXCP |d TEF |d OCLCO |d OCLCF |d N$T |d WYU |d OCLCA |d UKAHL |d VT2 |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ |d SFB | ||
019 | |a 1066519192 |a 1235845910 | ||
020 | |a 9781910190388 |q electronic bk. | ||
020 | |a 1910190381 |q electronic bk. | ||
020 | |z 9781910190371 |q (print) | ||
020 | |z 1910190373 | ||
035 | |a (OCoLC)949884670 |z (OCoLC)1066519192 |z (OCoLC)1235845910 | ||
050 | 4 | |a QR92.B3 | |
060 | 0 | 0 | |a 2016 I-428 |
060 | 1 | 0 | |a QV 350 |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
082 | 7 | |a 615.7/922 |2 23 | |
049 | |a MAIN | ||
245 | 0 | 4 | |a The bacteriocins : |b current knowledge and future prospects / |c edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley. |
264 | 1 | |a Norfolk, UK : |b Caister Academic Press, |c 2016. | |
300 | |a 1 online resource. | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
500 | |a Includes index. | ||
588 | 0 | |a Online resource, title from PDF title page (Ebsco, viewed on August 16, 2016). | |
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a Intro -- Contents -- Contributors -- Current Books of Interest -- Preface -- Foreword -- 1: The Natural History of Bacteriocins -- Introduction -- The frequency of bacteriocin production -- Genotype effects -- Bacteriocin release: lysis versus excretion -- Multiple bacteriocin production -- Invasion dynamics of secreted bacteriocins -- Conclusions -- 2: Microcins and Other Bacteriocins: Bridging the Gaps Between Killing Strategies, Ecology and Applications -- Introduction -- A brief description of bacteriocins, defence weapons of bacteria -- Killing strategies of bacteriocins -- How to make and maintain efficient weapons: from biosynthetic pathways to bioengineering -- Immunity of the producers to their toxic peptides -- Ecological roles of bacteriocins -- Bridging the gaps between biosynthesis, killing strategies, ecology and applications -- 3: Nuclease Colicins: Mode of Action, Immunity and Mechanism of Import into Escherichia coli -- Overview of colicins and their import into E. coli -- Colicin structures -- Mechanism of action of nuclease colicin cytotoxic domains -- Affinity and specificity of nuclease colicin immunity protein complexes -- Receptor binding -- Translocator recruitment and the delivery of signalling epitopes to the periplasm -- Colicins recruit periplasmic proteins to form a translocon at the outer membrane -- Isolation of the ColE9 translocon reveals an unexpected path for the IUTD through the translocator OmpF -- The role of the proton motive force in colicin outer membrane translocation -- Colicin nuclease domain translocation across the inner membrane and the role of proteolytic processing -- Future perspectives -- 4: Capturing the Power of van der Waals Zone in the Creation of a Novel Family of Bacteriocin-based Antibiotics -- Looking to bacteria in our quest for novel antibiotics. | |
505 | 8 | |a The channel-forming bacteriocins provide a novel platform for creating antibiotics with designer specificities -- Expanding the bacterial killing breadth of pheromonicins -- Using van der Waals interactions to target eukaryotic cells -- The emerging pheromonicin platform -- Conclusions and future directions -- 5: The Use of Pyocins in Treating Pseudomonas aeruginosa Infections -- Introduction -- Pyocins: bacteriocins of P. aeruginosa -- Possible use of pyocins in treatment of P. aeruginosa infections -- Concluding remarks -- 6: Streptococcal Bacteriocin-producing Strains as Oral Probiotic Agents -- Introduction -- The salivaricins of Streptococcus salivarius -- Commercial development of oral streptococci for use as oral probiotics -- Concluding remarks -- 7: Treating Bovine Mastitis with Nisin: A Model for the Use of Protein Antimicrobials in Veterinary Medicine -- Introduction -- Mastitis -- a challenging infection in the dairy industry -- Current treatments and resistance landscape -- Nisin -- the next generation antimicrobial for mastitis control -- The hurdles of developing a protein-based therapy -- Future work -- Conclusion -- 8: The Phenotypic and Genotypic Landscape of Colicin Resistance -- Introduction -- Materials and methods -- Results -- Discussion -- Index. | |
520 | |a In this volume, a range of experts explore our current understanding of the biology of these important compounds, and identify the prospects for their use in medical and veterinary applications. In so doing, this volume introduces the vast diversity of bacteriocin molecules and mechanisms and brings readers to the cutting edge of a new 21st century approach to antibiotic discovery and design. Topics covered include: the natural history of bacteriocins; killing strategies and applications of microcins; the mode of action of nuclease colicins; the role of the van der Waals zone in the design of a new family of bacteriocins; the use of pyocins in the treatment of infections; the role of streptococccal bacteriocins as oral probiotics; veterinary applications of bacteriocins (nisin) in treating mastitis, and an exploration of the genetics of bacteriocin resistance. This volume is essential reading for everyone involved in antimicrobial research in academia, biotechnology companies, and the pharmaceutical industry and a recommended volume for all microbiology libraries. | ||
650 | 0 | |a Bacteriocins. |0 http://id.loc.gov/authorities/subjects/sh85010861 | |
650 | 1 | 2 | |a Bacteriocins |
650 | 6 | |a Bactériocines. | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 7 | |a Bacteriocins |2 fast | |
700 | 1 | |a Dorit, Robert L. |e editor. | |
700 | 1 | |a Roy, San M. |e editor. | |
700 | 1 | |a Riley, Margaret A. |e editor. | |
758 | |i has work: |a Bacteriocins (Dorit) (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGDqQFfg3w8HHvKyHWvDVP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |c Original |z 1910190373 |z 9781910190371 |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1238845 |3 Volltext |
938 | |a Askews and Holts Library Services |b ASKH |n AH30966687 | ||
938 | |a EBSCOhost |b EBSC |n 1238845 | ||
938 | |a YBP Library Services |b YANK |n 12994110 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn949884670 |
---|---|
_version_ | 1816882349260931072 |
adam_text | |
any_adam_object | |
author2 | Dorit, Robert L. Roy, San M. Riley, Margaret A. |
author2_role | edt edt edt |
author2_variant | r l d rl rld s m r sm smr m a r ma mar |
author_facet | Dorit, Robert L. Roy, San M. Riley, Margaret A. |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | Q - Science |
callnumber-label | QR92 |
callnumber-raw | QR92.B3 |
callnumber-search | QR92.B3 |
callnumber-sort | QR 292 B3 |
callnumber-subject | QR - Microbiology |
collection | ZDB-4-EBA |
contents | Intro -- Contents -- Contributors -- Current Books of Interest -- Preface -- Foreword -- 1: The Natural History of Bacteriocins -- Introduction -- The frequency of bacteriocin production -- Genotype effects -- Bacteriocin release: lysis versus excretion -- Multiple bacteriocin production -- Invasion dynamics of secreted bacteriocins -- Conclusions -- 2: Microcins and Other Bacteriocins: Bridging the Gaps Between Killing Strategies, Ecology and Applications -- Introduction -- A brief description of bacteriocins, defence weapons of bacteria -- Killing strategies of bacteriocins -- How to make and maintain efficient weapons: from biosynthetic pathways to bioengineering -- Immunity of the producers to their toxic peptides -- Ecological roles of bacteriocins -- Bridging the gaps between biosynthesis, killing strategies, ecology and applications -- 3: Nuclease Colicins: Mode of Action, Immunity and Mechanism of Import into Escherichia coli -- Overview of colicins and their import into E. coli -- Colicin structures -- Mechanism of action of nuclease colicin cytotoxic domains -- Affinity and specificity of nuclease colicin immunity protein complexes -- Receptor binding -- Translocator recruitment and the delivery of signalling epitopes to the periplasm -- Colicins recruit periplasmic proteins to form a translocon at the outer membrane -- Isolation of the ColE9 translocon reveals an unexpected path for the IUTD through the translocator OmpF -- The role of the proton motive force in colicin outer membrane translocation -- Colicin nuclease domain translocation across the inner membrane and the role of proteolytic processing -- Future perspectives -- 4: Capturing the Power of van der Waals Zone in the Creation of a Novel Family of Bacteriocin-based Antibiotics -- Looking to bacteria in our quest for novel antibiotics. The channel-forming bacteriocins provide a novel platform for creating antibiotics with designer specificities -- Expanding the bacterial killing breadth of pheromonicins -- Using van der Waals interactions to target eukaryotic cells -- The emerging pheromonicin platform -- Conclusions and future directions -- 5: The Use of Pyocins in Treating Pseudomonas aeruginosa Infections -- Introduction -- Pyocins: bacteriocins of P. aeruginosa -- Possible use of pyocins in treatment of P. aeruginosa infections -- Concluding remarks -- 6: Streptococcal Bacteriocin-producing Strains as Oral Probiotic Agents -- Introduction -- The salivaricins of Streptococcus salivarius -- Commercial development of oral streptococci for use as oral probiotics -- Concluding remarks -- 7: Treating Bovine Mastitis with Nisin: A Model for the Use of Protein Antimicrobials in Veterinary Medicine -- Introduction -- Mastitis -- a challenging infection in the dairy industry -- Current treatments and resistance landscape -- Nisin -- the next generation antimicrobial for mastitis control -- The hurdles of developing a protein-based therapy -- Future work -- Conclusion -- 8: The Phenotypic and Genotypic Landscape of Colicin Resistance -- Introduction -- Materials and methods -- Results -- Discussion -- Index. |
ctrlnum | (OCoLC)949884670 |
dewey-full | 615.7/922 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7/922 |
dewey-search | 615.7/922 |
dewey-sort | 3615.7 3922 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06432cam a2200577 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn949884670</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">160517s2016 enk o 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">TEF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">N$T</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKAHL</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">SFB</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1066519192</subfield><subfield code="a">1235845910</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910190388</subfield><subfield code="q">electronic bk.</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910190381</subfield><subfield code="q">electronic bk.</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781910190371</subfield><subfield code="q">(print)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1910190373</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)949884670</subfield><subfield code="z">(OCoLC)1066519192</subfield><subfield code="z">(OCoLC)1235845910</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR92.B3</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">2016 I-428</subfield></datafield><datafield tag="060" ind1="1" ind2="0"><subfield code="a">QV 350</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.7/922</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="4"><subfield code="a">The bacteriocins :</subfield><subfield code="b">current knowledge and future prospects /</subfield><subfield code="c">edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Norfolk, UK :</subfield><subfield code="b">Caister Academic Press,</subfield><subfield code="c">2016.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource, title from PDF title page (Ebsco, viewed on August 16, 2016).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Contents -- Contributors -- Current Books of Interest -- Preface -- Foreword -- 1: The Natural History of Bacteriocins -- Introduction -- The frequency of bacteriocin production -- Genotype effects -- Bacteriocin release: lysis versus excretion -- Multiple bacteriocin production -- Invasion dynamics of secreted bacteriocins -- Conclusions -- 2: Microcins and Other Bacteriocins: Bridging the Gaps Between Killing Strategies, Ecology and Applications -- Introduction -- A brief description of bacteriocins, defence weapons of bacteria -- Killing strategies of bacteriocins -- How to make and maintain efficient weapons: from biosynthetic pathways to bioengineering -- Immunity of the producers to their toxic peptides -- Ecological roles of bacteriocins -- Bridging the gaps between biosynthesis, killing strategies, ecology and applications -- 3: Nuclease Colicins: Mode of Action, Immunity and Mechanism of Import into Escherichia coli -- Overview of colicins and their import into E. coli -- Colicin structures -- Mechanism of action of nuclease colicin cytotoxic domains -- Affinity and specificity of nuclease colicin immunity protein complexes -- Receptor binding -- Translocator recruitment and the delivery of signalling epitopes to the periplasm -- Colicins recruit periplasmic proteins to form a translocon at the outer membrane -- Isolation of the ColE9 translocon reveals an unexpected path for the IUTD through the translocator OmpF -- The role of the proton motive force in colicin outer membrane translocation -- Colicin nuclease domain translocation across the inner membrane and the role of proteolytic processing -- Future perspectives -- 4: Capturing the Power of van der Waals Zone in the Creation of a Novel Family of Bacteriocin-based Antibiotics -- Looking to bacteria in our quest for novel antibiotics.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The channel-forming bacteriocins provide a novel platform for creating antibiotics with designer specificities -- Expanding the bacterial killing breadth of pheromonicins -- Using van der Waals interactions to target eukaryotic cells -- The emerging pheromonicin platform -- Conclusions and future directions -- 5: The Use of Pyocins in Treating Pseudomonas aeruginosa Infections -- Introduction -- Pyocins: bacteriocins of P. aeruginosa -- Possible use of pyocins in treatment of P. aeruginosa infections -- Concluding remarks -- 6: Streptococcal Bacteriocin-producing Strains as Oral Probiotic Agents -- Introduction -- The salivaricins of Streptococcus salivarius -- Commercial development of oral streptococci for use as oral probiotics -- Concluding remarks -- 7: Treating Bovine Mastitis with Nisin: A Model for the Use of Protein Antimicrobials in Veterinary Medicine -- Introduction -- Mastitis -- a challenging infection in the dairy industry -- Current treatments and resistance landscape -- Nisin -- the next generation antimicrobial for mastitis control -- The hurdles of developing a protein-based therapy -- Future work -- Conclusion -- 8: The Phenotypic and Genotypic Landscape of Colicin Resistance -- Introduction -- Materials and methods -- Results -- Discussion -- Index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this volume, a range of experts explore our current understanding of the biology of these important compounds, and identify the prospects for their use in medical and veterinary applications. In so doing, this volume introduces the vast diversity of bacteriocin molecules and mechanisms and brings readers to the cutting edge of a new 21st century approach to antibiotic discovery and design. Topics covered include: the natural history of bacteriocins; killing strategies and applications of microcins; the mode of action of nuclease colicins; the role of the van der Waals zone in the design of a new family of bacteriocins; the use of pyocins in the treatment of infections; the role of streptococccal bacteriocins as oral probiotics; veterinary applications of bacteriocins (nisin) in treating mastitis, and an exploration of the genetics of bacteriocin resistance. This volume is essential reading for everyone involved in antimicrobial research in academia, biotechnology companies, and the pharmaceutical industry and a recommended volume for all microbiology libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bacteriocins.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85010861</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Bacteriocins</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Bactériocines.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bacteriocins</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dorit, Robert L.</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roy, San M.</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riley, Margaret A.</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Bacteriocins (Dorit) (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGDqQFfg3w8HHvKyHWvDVP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="c">Original</subfield><subfield code="z">1910190373</subfield><subfield code="z">9781910190371</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1238845</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH30966687</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1238845</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">12994110</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-ocn949884670 |
illustrated | Not Illustrated |
indexdate | 2024-11-27T13:27:12Z |
institution | BVB |
isbn | 9781910190388 1910190381 |
language | English |
oclc_num | 949884670 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource. |
psigel | ZDB-4-EBA |
publishDate | 2016 |
publishDateSearch | 2016 |
publishDateSort | 2016 |
publisher | Caister Academic Press, |
record_format | marc |
spelling | The bacteriocins : current knowledge and future prospects / edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley. Norfolk, UK : Caister Academic Press, 2016. 1 online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes index. Online resource, title from PDF title page (Ebsco, viewed on August 16, 2016). Includes bibliographical references and index. Intro -- Contents -- Contributors -- Current Books of Interest -- Preface -- Foreword -- 1: The Natural History of Bacteriocins -- Introduction -- The frequency of bacteriocin production -- Genotype effects -- Bacteriocin release: lysis versus excretion -- Multiple bacteriocin production -- Invasion dynamics of secreted bacteriocins -- Conclusions -- 2: Microcins and Other Bacteriocins: Bridging the Gaps Between Killing Strategies, Ecology and Applications -- Introduction -- A brief description of bacteriocins, defence weapons of bacteria -- Killing strategies of bacteriocins -- How to make and maintain efficient weapons: from biosynthetic pathways to bioengineering -- Immunity of the producers to their toxic peptides -- Ecological roles of bacteriocins -- Bridging the gaps between biosynthesis, killing strategies, ecology and applications -- 3: Nuclease Colicins: Mode of Action, Immunity and Mechanism of Import into Escherichia coli -- Overview of colicins and their import into E. coli -- Colicin structures -- Mechanism of action of nuclease colicin cytotoxic domains -- Affinity and specificity of nuclease colicin immunity protein complexes -- Receptor binding -- Translocator recruitment and the delivery of signalling epitopes to the periplasm -- Colicins recruit periplasmic proteins to form a translocon at the outer membrane -- Isolation of the ColE9 translocon reveals an unexpected path for the IUTD through the translocator OmpF -- The role of the proton motive force in colicin outer membrane translocation -- Colicin nuclease domain translocation across the inner membrane and the role of proteolytic processing -- Future perspectives -- 4: Capturing the Power of van der Waals Zone in the Creation of a Novel Family of Bacteriocin-based Antibiotics -- Looking to bacteria in our quest for novel antibiotics. The channel-forming bacteriocins provide a novel platform for creating antibiotics with designer specificities -- Expanding the bacterial killing breadth of pheromonicins -- Using van der Waals interactions to target eukaryotic cells -- The emerging pheromonicin platform -- Conclusions and future directions -- 5: The Use of Pyocins in Treating Pseudomonas aeruginosa Infections -- Introduction -- Pyocins: bacteriocins of P. aeruginosa -- Possible use of pyocins in treatment of P. aeruginosa infections -- Concluding remarks -- 6: Streptococcal Bacteriocin-producing Strains as Oral Probiotic Agents -- Introduction -- The salivaricins of Streptococcus salivarius -- Commercial development of oral streptococci for use as oral probiotics -- Concluding remarks -- 7: Treating Bovine Mastitis with Nisin: A Model for the Use of Protein Antimicrobials in Veterinary Medicine -- Introduction -- Mastitis -- a challenging infection in the dairy industry -- Current treatments and resistance landscape -- Nisin -- the next generation antimicrobial for mastitis control -- The hurdles of developing a protein-based therapy -- Future work -- Conclusion -- 8: The Phenotypic and Genotypic Landscape of Colicin Resistance -- Introduction -- Materials and methods -- Results -- Discussion -- Index. In this volume, a range of experts explore our current understanding of the biology of these important compounds, and identify the prospects for their use in medical and veterinary applications. In so doing, this volume introduces the vast diversity of bacteriocin molecules and mechanisms and brings readers to the cutting edge of a new 21st century approach to antibiotic discovery and design. Topics covered include: the natural history of bacteriocins; killing strategies and applications of microcins; the mode of action of nuclease colicins; the role of the van der Waals zone in the design of a new family of bacteriocins; the use of pyocins in the treatment of infections; the role of streptococccal bacteriocins as oral probiotics; veterinary applications of bacteriocins (nisin) in treating mastitis, and an exploration of the genetics of bacteriocin resistance. This volume is essential reading for everyone involved in antimicrobial research in academia, biotechnology companies, and the pharmaceutical industry and a recommended volume for all microbiology libraries. Bacteriocins. http://id.loc.gov/authorities/subjects/sh85010861 Bacteriocins Bactériocines. MEDICAL / Pharmacology bisacsh Bacteriocins fast Dorit, Robert L. editor. Roy, San M. editor. Riley, Margaret A. editor. has work: Bacteriocins (Dorit) (Text) https://id.oclc.org/worldcat/entity/E39PCGDqQFfg3w8HHvKyHWvDVP https://id.oclc.org/worldcat/ontology/hasWork Original 1910190373 9781910190371 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1238845 Volltext |
spellingShingle | The bacteriocins : current knowledge and future prospects / Intro -- Contents -- Contributors -- Current Books of Interest -- Preface -- Foreword -- 1: The Natural History of Bacteriocins -- Introduction -- The frequency of bacteriocin production -- Genotype effects -- Bacteriocin release: lysis versus excretion -- Multiple bacteriocin production -- Invasion dynamics of secreted bacteriocins -- Conclusions -- 2: Microcins and Other Bacteriocins: Bridging the Gaps Between Killing Strategies, Ecology and Applications -- Introduction -- A brief description of bacteriocins, defence weapons of bacteria -- Killing strategies of bacteriocins -- How to make and maintain efficient weapons: from biosynthetic pathways to bioengineering -- Immunity of the producers to their toxic peptides -- Ecological roles of bacteriocins -- Bridging the gaps between biosynthesis, killing strategies, ecology and applications -- 3: Nuclease Colicins: Mode of Action, Immunity and Mechanism of Import into Escherichia coli -- Overview of colicins and their import into E. coli -- Colicin structures -- Mechanism of action of nuclease colicin cytotoxic domains -- Affinity and specificity of nuclease colicin immunity protein complexes -- Receptor binding -- Translocator recruitment and the delivery of signalling epitopes to the periplasm -- Colicins recruit periplasmic proteins to form a translocon at the outer membrane -- Isolation of the ColE9 translocon reveals an unexpected path for the IUTD through the translocator OmpF -- The role of the proton motive force in colicin outer membrane translocation -- Colicin nuclease domain translocation across the inner membrane and the role of proteolytic processing -- Future perspectives -- 4: Capturing the Power of van der Waals Zone in the Creation of a Novel Family of Bacteriocin-based Antibiotics -- Looking to bacteria in our quest for novel antibiotics. The channel-forming bacteriocins provide a novel platform for creating antibiotics with designer specificities -- Expanding the bacterial killing breadth of pheromonicins -- Using van der Waals interactions to target eukaryotic cells -- The emerging pheromonicin platform -- Conclusions and future directions -- 5: The Use of Pyocins in Treating Pseudomonas aeruginosa Infections -- Introduction -- Pyocins: bacteriocins of P. aeruginosa -- Possible use of pyocins in treatment of P. aeruginosa infections -- Concluding remarks -- 6: Streptococcal Bacteriocin-producing Strains as Oral Probiotic Agents -- Introduction -- The salivaricins of Streptococcus salivarius -- Commercial development of oral streptococci for use as oral probiotics -- Concluding remarks -- 7: Treating Bovine Mastitis with Nisin: A Model for the Use of Protein Antimicrobials in Veterinary Medicine -- Introduction -- Mastitis -- a challenging infection in the dairy industry -- Current treatments and resistance landscape -- Nisin -- the next generation antimicrobial for mastitis control -- The hurdles of developing a protein-based therapy -- Future work -- Conclusion -- 8: The Phenotypic and Genotypic Landscape of Colicin Resistance -- Introduction -- Materials and methods -- Results -- Discussion -- Index. Bacteriocins. http://id.loc.gov/authorities/subjects/sh85010861 Bacteriocins Bactériocines. MEDICAL / Pharmacology bisacsh Bacteriocins fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85010861 |
title | The bacteriocins : current knowledge and future prospects / |
title_auth | The bacteriocins : current knowledge and future prospects / |
title_exact_search | The bacteriocins : current knowledge and future prospects / |
title_full | The bacteriocins : current knowledge and future prospects / edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley. |
title_fullStr | The bacteriocins : current knowledge and future prospects / edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley. |
title_full_unstemmed | The bacteriocins : current knowledge and future prospects / edited by Robert Dorit, Sandra M. Roy and Margaret A. Riley. |
title_short | The bacteriocins : |
title_sort | bacteriocins current knowledge and future prospects |
title_sub | current knowledge and future prospects / |
topic | Bacteriocins. http://id.loc.gov/authorities/subjects/sh85010861 Bacteriocins Bactériocines. MEDICAL / Pharmacology bisacsh Bacteriocins fast |
topic_facet | Bacteriocins. Bacteriocins Bactériocines. MEDICAL / Pharmacology |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1238845 |
work_keys_str_mv | AT doritrobertl thebacteriocinscurrentknowledgeandfutureprospects AT roysanm thebacteriocinscurrentknowledgeandfutureprospects AT rileymargareta thebacteriocinscurrentknowledgeandfutureprospects AT doritrobertl bacteriocinscurrentknowledgeandfutureprospects AT roysanm bacteriocinscurrentknowledgeandfutureprospects AT rileymargareta bacteriocinscurrentknowledgeandfutureprospects |